Genelabs Technologies
Biotechnology Research
126 employees
- Employees
- 126
Genelabs Technologies Overview
- Phone Number
- Available in AeroLeads
- Website
- genelabs.com
- Industry
- Biotechnology Research
- Employees
- 126
- Funding
- 9.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Genelabs Technologies
Genelabs is a biopharmaceutical company focused on the discovery and development of novel compounds for infectious diseases. In addition to a late-stage drug candidate for Hepatitis E partnered with GlaxoSmithKline, the company is advancing multiple partnered and proprietary compounds designed to selectively inhibit replication of the hepatitis C virus, targeting the HCV viral proteins - NS5B polymerase, NS4B, and NS5A. In January 2009 Genelabs was bought by GlaxoSmithKline.
Genelabs Technologies Contact Details
Employees by Management Level
Individual contributor
5 profiles
Director
4 profiles
Executive
2 profiles
Manager
2 profiles
Senior / Lead
2 profiles
Associate / junior
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 9 | 9 | 1 |
| Executive | 4 | 4 | 1 |
Genelabs Technologies Tech Stack
Data / AI
2 profiles
Compare Similar Companies to Genelabs Technologies
Hologic (Formerly Gen-Probe)
Biotechnology Research
Genetech
Biotechnology
Hayleys Agro Biotech Pvt Ltd, Srilanka
Biotechnology Research
Genelabs Medical (Pvt) Ltd
Biotechnology Research
CaroGen Corporation
Biotechnology
GenePace Laboratories
Hospitals And Health Care
Genelabs
Wellness And Fitness Services
Sri Biotech Lanka (PVT) Ltd
Biotechnology Research
Biomedx
Health, Wellness & Fitness
Cor Therapeutics
Pharmaceutical Manufacturing